Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant
radiochemotherapy has no prognostic relevance.
Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and
radiochemotherapy. Part 2: diagnosis and management of mucositis.
Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant
radiochemotherapy in rectal cancer: preliminary results.
Per the study's protocol, newly diagnosed patients with advanced primary squamous cell carcinoma are treated with the Multikine treatment regimen for three weeks prior to receiving the Standard of Care, which involves surgery, radiation and/or concurrent
radiochemotherapy.
The primary objective of our Phase 3 study is to demonstrate that, by administering the Multikine treatment regimen prior to the current standard of care therapy, surgery followed by radiotherapy or followed by combined
radiochemotherapy, we can achieve a 10% increase in overall survival of the Multikine treated head and neck cancer patients.
Such a positive response was previously reported in a randomized clinical study in which advanced head and neck cancer patients received
radiochemotherapy and were analyzed for oral cavity toxicities (30).
There is a tendency of a potential benefit regarding radiotherapy or
radiochemotherapy in patients with resection margin positive tumors or even with unresectable tumors (16-18).
15-year survival rates after transurethral resection and
radiochemotherapy or radiation in bladder cancer treatment.
Complete resection of the tumor is still the best choice for patients with CPPs, considering the side effects of
radiochemotherapy. The findings of our study are consistent with those of previous reports.[1],[3],[6],[16],[17]
In unresectable or resectable carcinomas of the head and neck, surgery and
radiochemotherapy are routinely performed; therefore, the use of enteral prophylactic approach, as jejunostomy, allows improving the quality of life of patients and prevents the complications of malnutrition during treatment.
Assessment of response to neoadjuvant
radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer.
Swallowing after non-surgical treatment (radiation therapy/
radiochemotherapy protocol) of laryngeal cancer.
